nodes	percent_of_prediction	percent_of_DWPC	metapath
Sucralfate—Venous thrombosis—Carboplatin—esophageal cancer	0.0415	0.175	CcSEcCtD
Sucralfate—Fluid overload—Carboplatin—esophageal cancer	0.036	0.152	CcSEcCtD
Sucralfate—EGF—exocrine gland—esophageal cancer	0.0273	0.114	CbGeAlD
Sucralfate—Extravasation—Carboplatin—esophageal cancer	0.0257	0.108	CcSEcCtD
Sucralfate—PGA5—digestive system—esophageal cancer	0.0212	0.0887	CbGeAlD
Sucralfate—Haemolysis—Cisplatin—esophageal cancer	0.0207	0.0872	CcSEcCtD
Sucralfate—Phlebitis—Carboplatin—esophageal cancer	0.0189	0.0796	CcSEcCtD
Sucralfate—EGF—neck—esophageal cancer	0.0174	0.0728	CbGeAlD
Sucralfate—FGG—lung—esophageal cancer	0.0156	0.0652	CbGeAlD
Sucralfate—FGB—digestive system—esophageal cancer	0.0144	0.0603	CbGeAlD
Sucralfate—FGA—digestive system—esophageal cancer	0.0124	0.0516	CbGeAlD
Sucralfate—Venous thrombosis—Cisplatin—esophageal cancer	0.0122	0.0514	CcSEcCtD
Sucralfate—FGB—lung—esophageal cancer	0.0121	0.0503	CbGeAlD
Sucralfate—EGF—epithelium—esophageal cancer	0.0119	0.0495	CbGeAlD
Sucralfate—EGF—smooth muscle tissue—esophageal cancer	0.0114	0.0477	CbGeAlD
Sucralfate—FGG—lymph node—esophageal cancer	0.0107	0.0446	CbGeAlD
Sucralfate—Fluid overload—Cisplatin—esophageal cancer	0.0106	0.0446	CcSEcCtD
Sucralfate—EGF—trachea—esophageal cancer	0.0105	0.0438	CbGeAlD
Sucralfate—FGA—lung—esophageal cancer	0.0103	0.0431	CbGeAlD
Sucralfate—FGF2—bronchus—esophageal cancer	0.0103	0.043	CbGeAlD
Sucralfate—FGF2—smooth muscle tissue—esophageal cancer	0.0101	0.0421	CbGeAlD
Sucralfate—FGF2—trachea—esophageal cancer	0.00926	0.0386	CbGeAlD
Sucralfate—EGF—digestive system—esophageal cancer	0.00903	0.0377	CbGeAlD
Sucralfate—Venous thrombosis—Capecitabine—esophageal cancer	0.00897	0.0379	CcSEcCtD
Sucralfate—Infection—Carboplatin—esophageal cancer	0.00794	0.0335	CcSEcCtD
Sucralfate—EGF—lung—esophageal cancer	0.00754	0.0315	CbGeAlD
Sucralfate—Extravasation—Cisplatin—esophageal cancer	0.00753	0.0318	CcSEcCtD
Sucralfate—FGF2—lung—esophageal cancer	0.00665	0.0278	CbGeAlD
Sucralfate—Body temperature increased—Carboplatin—esophageal cancer	0.00632	0.0267	CcSEcCtD
Sucralfate—Phlebitis—Cisplatin—esophageal cancer	0.00553	0.0234	CcSEcCtD
Sucralfate—EGF—lymph node—esophageal cancer	0.00516	0.0215	CbGeAlD
Sucralfate—Lung disorder—Methotrexate—esophageal cancer	0.00509	0.0215	CcSEcCtD
Sucralfate—Hyponatraemia—Cisplatin—esophageal cancer	0.00479	0.0202	CcSEcCtD
Sucralfate—FGF2—lymph node—esophageal cancer	0.00455	0.019	CbGeAlD
Sucralfate—Extravasation—Methotrexate—esophageal cancer	0.00413	0.0174	CcSEcCtD
Sucralfate—Phlebitis—Capecitabine—esophageal cancer	0.00408	0.0172	CcSEcCtD
Sucralfate—Hyponatraemia—Capecitabine—esophageal cancer	0.00353	0.0149	CcSEcCtD
Sucralfate—Oedema—Cisplatin—esophageal cancer	0.00234	0.00989	CcSEcCtD
Sucralfate—Infection—Cisplatin—esophageal cancer	0.00233	0.00983	CcSEcCtD
Sucralfate—Body temperature increased—Cisplatin—esophageal cancer	0.00185	0.00782	CcSEcCtD
Sucralfate—ALB—lymph node—esophageal cancer	0.00178	0.00744	CbGeAlD
Sucralfate—Oedema—Capecitabine—esophageal cancer	0.00173	0.00729	CcSEcCtD
Sucralfate—Infection—Capecitabine—esophageal cancer	0.00172	0.00724	CcSEcCtD
Sucralfate—Body temperature increased—Capecitabine—esophageal cancer	0.00137	0.00576	CcSEcCtD
Sucralfate—Infection—Methotrexate—esophageal cancer	0.00128	0.00539	CcSEcCtD
Sucralfate—Body temperature increased—Methotrexate—esophageal cancer	0.00102	0.00429	CcSEcCtD
Sucralfate—EGF—Signaling Pathways—PSME1—esophageal cancer	0.000115	0.000219	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—NOTCH1—esophageal cancer	0.000114	0.000218	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—ANXA1—esophageal cancer	0.000114	0.000218	CbGpPWpGaD
Sucralfate—FGF2—Immune System—PSME1—esophageal cancer	0.000112	0.000214	CbGpPWpGaD
Sucralfate—FGF2—Immune System—PSME2—esophageal cancer	0.000112	0.000214	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	0.000112	0.000213	CbGpPWpGaD
Sucralfate—FGA—Disease—NOS3—esophageal cancer	0.000111	0.000213	CbGpPWpGaD
Sucralfate—FGF2—Immune System—HSPA5—esophageal cancer	0.000111	0.000212	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—SST—esophageal cancer	0.000111	0.000212	CbGpPWpGaD
Sucralfate—FGF2—B Cell Activation—PIK3CA—esophageal cancer	0.00011	0.00021	CbGpPWpGaD
Sucralfate—FGF2—Disease—B2M—esophageal cancer	0.00011	0.000209	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—EP300—esophageal cancer	0.000109	0.000209	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—HIF1A—esophageal cancer	0.000109	0.000208	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—NOTCH3—esophageal cancer	0.000108	0.000206	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—GHRL—esophageal cancer	0.000108	0.000206	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	0.000108	0.000206	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CALR—esophageal cancer	0.000108	0.000206	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—TLR4—esophageal cancer	0.000107	0.000205	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—HIF1A—esophageal cancer	0.000107	0.000204	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—HIF1A—esophageal cancer	0.000107	0.000204	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—FBXW7—esophageal cancer	0.000106	0.000203	CbGpPWpGaD
Sucralfate—FGF2—Disease—ENO1—esophageal cancer	0.000105	0.000201	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—PIK3CA—esophageal cancer	0.000105	0.000201	CbGpPWpGaD
Sucralfate—FGA—Disease—ERBB2—esophageal cancer	0.000104	0.000199	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—KDR—esophageal cancer	0.000104	0.000199	CbGpPWpGaD
Sucralfate—FGF2—Immune System—FBXW7—esophageal cancer	0.000104	0.000199	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000104	0.000199	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—ELMO1—esophageal cancer	0.000104	0.000198	CbGpPWpGaD
Sucralfate—FGF2—Disease—PSME2—esophageal cancer	0.000104	0.000198	CbGpPWpGaD
Sucralfate—FGF2—Disease—PSME1—esophageal cancer	0.000104	0.000198	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—CREBBP—esophageal cancer	0.000104	0.000198	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—CDKN1A—esophageal cancer	0.000103	0.000198	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—KDR—esophageal cancer	0.000102	0.000195	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—KDR—esophageal cancer	0.000102	0.000195	CbGpPWpGaD
Sucralfate—FGA—Disease—PTGS2—esophageal cancer	0.000102	0.000195	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—AKAP13—esophageal cancer	0.000101	0.000193	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—CFL1—esophageal cancer	0.000101	0.000192	CbGpPWpGaD
Sucralfate—FGF2—Immune System—HMGB1—esophageal cancer	9.95e-05	0.00019	CbGpPWpGaD
Sucralfate—FGF2—Disease—CALR—esophageal cancer	9.94e-05	0.00019	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—CDKN1A—esophageal cancer	9.93e-05	0.00019	CbGpPWpGaD
Sucralfate—EGF—Immune System—TLR4—esophageal cancer	9.85e-05	0.000188	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—EP300—esophageal cancer	9.84e-05	0.000188	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—NOTCH1—esophageal cancer	9.81e-05	0.000187	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—NOTCH2—esophageal cancer	9.69e-05	0.000185	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—NOTCH1—esophageal cancer	9.62e-05	0.000184	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—NOTCH1—esophageal cancer	9.62e-05	0.000184	CbGpPWpGaD
Sucralfate—FGF2—Disease—FBXW7—esophageal cancer	9.61e-05	0.000184	CbGpPWpGaD
Sucralfate—EGF—Disease—HIF1A—esophageal cancer	9.51e-05	0.000182	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—GNG7—esophageal cancer	9.48e-05	0.000181	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—HIST1H2BM—esophageal cancer	9.35e-05	0.000179	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—EGFR—esophageal cancer	9.31e-05	0.000178	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—PDE4D—esophageal cancer	9.26e-05	0.000177	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—TP53—esophageal cancer	9.21e-05	0.000176	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—CASP8—esophageal cancer	9.19e-05	0.000175	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—CREBBP—esophageal cancer	9.14e-05	0.000175	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	9.07e-05	0.000173	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—ABCC2—esophageal cancer	9.04e-05	0.000173	CbGpPWpGaD
Sucralfate—FGA—Disease—CDKN1A—esophageal cancer	8.91e-05	0.00017	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CREBBP—esophageal cancer	8.9e-05	0.00017	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—GNG7—esophageal cancer	8.81e-05	0.000168	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CREBBP—esophageal cancer	8.72e-05	0.000167	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CREBBP—esophageal cancer	8.72e-05	0.000167	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—ERBB2—esophageal cancer	8.67e-05	0.000166	CbGpPWpGaD
Sucralfate—EGF—Disease—NOS2—esophageal cancer	8.65e-05	0.000165	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—TGFBR2—esophageal cancer	8.6e-05	0.000164	CbGpPWpGaD
Sucralfate—EGF—Disease—NOTCH1—esophageal cancer	8.57e-05	0.000164	CbGpPWpGaD
Sucralfate—FGA—Disease—EP300—esophageal cancer	8.48e-05	0.000162	CbGpPWpGaD
Sucralfate—EGF—Immune System—CASP8—esophageal cancer	8.45e-05	0.000161	CbGpPWpGaD
Sucralfate—EGF—Immune System—CREBBP—esophageal cancer	8.42e-05	0.000161	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—EGFR—esophageal cancer	8.39e-05	0.00016	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—XIAP—esophageal cancer	8.26e-05	0.000158	CbGpPWpGaD
Sucralfate—FGF2—Immune System—ABL1—esophageal cancer	8.23e-05	0.000157	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—GNG7—esophageal cancer	8.2e-05	0.000157	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—SMAD4—esophageal cancer	8.14e-05	0.000156	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—PIK3CA—esophageal cancer	8.09e-05	0.000154	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—PIK3CA—esophageal cancer	8.08e-05	0.000154	CbGpPWpGaD
Sucralfate—ALB—Metabolism—SLC52A3—esophageal cancer	8.06e-05	0.000154	CbGpPWpGaD
Sucralfate—ALB—Metabolism—BLVRB—esophageal cancer	8.06e-05	0.000154	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—EGFR—esophageal cancer	8.05e-05	0.000154	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—NOS3—esophageal cancer	7.97e-05	0.000152	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—BCL2—esophageal cancer	7.88e-05	0.000151	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—TP53—esophageal cancer	7.82e-05	0.000149	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CTNNA1—esophageal cancer	7.81e-05	0.000149	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—NOS3—esophageal cancer	7.81e-05	0.000149	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—NOS3—esophageal cancer	7.81e-05	0.000149	CbGpPWpGaD
Sucralfate—FGF2—Disease—TGFBR2—esophageal cancer	7.77e-05	0.000148	CbGpPWpGaD
Sucralfate—EGF—Disease—CREBBP—esophageal cancer	7.77e-05	0.000148	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CXCL2—esophageal cancer	7.76e-05	0.000148	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—HSPA5—esophageal cancer	7.72e-05	0.000148	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—ERBB2—esophageal cancer	7.66e-05	0.000146	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—ERBB2—esophageal cancer	7.45e-05	0.000142	CbGpPWpGaD
Sucralfate—FGA—Disease—MYC—esophageal cancer	7.39e-05	0.000141	CbGpPWpGaD
Sucralfate—FGF2—Disease—SMAD4—esophageal cancer	7.36e-05	0.000141	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—ERBB2—esophageal cancer	7.35e-05	0.00014	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—ERBB2—esophageal cancer	7.3e-05	0.000139	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—ERBB2—esophageal cancer	7.3e-05	0.000139	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—PIK3CA—esophageal cancer	7.28e-05	0.000139	CbGpPWpGaD
Sucralfate—EGF—Immune System—BCL2—esophageal cancer	7.25e-05	0.000139	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—PSME2—esophageal cancer	7.25e-05	0.000139	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—PSME1—esophageal cancer	7.25e-05	0.000139	CbGpPWpGaD
Sucralfate—FGA—Disease—EGFR—esophageal cancer	7.23e-05	0.000138	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—ANXA1—esophageal cancer	7.22e-05	0.000138	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	7.2e-05	0.000138	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—EP300—esophageal cancer	7.05e-05	0.000135	CbGpPWpGaD
Sucralfate—EGF—Immune System—ERBB2—esophageal cancer	7.05e-05	0.000135	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—SST—esophageal cancer	7.02e-05	0.000134	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—PIK3CA—esophageal cancer	6.99e-05	0.000134	CbGpPWpGaD
Sucralfate—EGF—Disease—NOS3—esophageal cancer	6.96e-05	0.000133	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CA1—esophageal cancer	6.85e-05	0.000131	CbGpPWpGaD
Sucralfate—ALB—Metabolism—SLC10A2—esophageal cancer	6.85e-05	0.000131	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—NOTCH3—esophageal cancer	6.84e-05	0.000131	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—GHRL—esophageal cancer	6.84e-05	0.000131	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—FBXW7—esophageal cancer	6.73e-05	0.000129	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—HIF1A—esophageal cancer	6.66e-05	0.000127	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CCND1—esophageal cancer	6.58e-05	0.000126	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—CDKN1A—esophageal cancer	6.54e-05	0.000125	CbGpPWpGaD
Sucralfate—EGF—Disease—ERBB2—esophageal cancer	6.51e-05	0.000124	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CCND1—esophageal cancer	6.45e-05	0.000123	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CCND1—esophageal cancer	6.45e-05	0.000123	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—KDR—esophageal cancer	6.37e-05	0.000122	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CDKN1A—esophageal cancer	6.37e-05	0.000122	CbGpPWpGaD
Sucralfate—EGF—Disease—PTGS2—esophageal cancer	6.36e-05	0.000122	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—CDKN1A—esophageal cancer	6.28e-05	0.00012	CbGpPWpGaD
Sucralfate—FGA—Disease—PIK3CA—esophageal cancer	6.27e-05	0.00012	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CA2—esophageal cancer	6.27e-05	0.00012	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CDKN1A—esophageal cancer	6.24e-05	0.000119	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CDKN1A—esophageal cancer	6.24e-05	0.000119	CbGpPWpGaD
Sucralfate—FGF2—Immune System—TLR4—esophageal cancer	6.24e-05	0.000119	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—EP300—esophageal cancer	6.23e-05	0.000119	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—NOTCH2—esophageal cancer	6.14e-05	0.000117	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	6.13e-05	0.000117	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—EP300—esophageal cancer	6.06e-05	0.000116	CbGpPWpGaD
Sucralfate—EGF—Immune System—CDKN1A—esophageal cancer	6.02e-05	0.000115	CbGpPWpGaD
Sucralfate—FGF2—Disease—HIF1A—esophageal cancer	6.02e-05	0.000115	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—EGFR—esophageal cancer	6.01e-05	0.000115	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—NOTCH1—esophageal cancer	6e-05	0.000115	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—EP300—esophageal cancer	5.94e-05	0.000113	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—EP300—esophageal cancer	5.94e-05	0.000113	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PLCE1—esophageal cancer	5.83e-05	0.000111	CbGpPWpGaD
Sucralfate—ALB—Metabolism—ADH7—esophageal cancer	5.83e-05	0.000111	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	5.76e-05	0.00011	CbGpPWpGaD
Sucralfate—EGF—Immune System—EP300—esophageal cancer	5.73e-05	0.000109	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—ABL1—esophageal cancer	5.72e-05	0.000109	CbGpPWpGaD
Sucralfate—EGF—Disease—CDKN1A—esophageal cancer	5.56e-05	0.000106	CbGpPWpGaD
Sucralfate—FGF2—Disease—NOS2—esophageal cancer	5.48e-05	0.000105	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—TGFBR2—esophageal cancer	5.44e-05	0.000104	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CREBBP—esophageal cancer	5.44e-05	0.000104	CbGpPWpGaD
Sucralfate—FGF2—Disease—NOTCH1—esophageal cancer	5.42e-05	0.000104	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CASP8—esophageal cancer	5.35e-05	0.000102	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CREBBP—esophageal cancer	5.33e-05	0.000102	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—EGFR—esophageal cancer	5.31e-05	0.000101	CbGpPWpGaD
Sucralfate—EGF—Disease—EP300—esophageal cancer	5.29e-05	0.000101	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—MYC—esophageal cancer	5.28e-05	0.000101	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—MYC—esophageal cancer	5.17e-05	9.88e-05	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—MYC—esophageal cancer	5.17e-05	9.88e-05	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—EGFR—esophageal cancer	5.17e-05	9.87e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—SMAD4—esophageal cancer	5.15e-05	9.84e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—ADH1B—esophageal cancer	5.11e-05	9.76e-05	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—EGFR—esophageal cancer	5.1e-05	9.74e-05	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—EGFR—esophageal cancer	5.06e-05	9.67e-05	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—EGFR—esophageal cancer	5.06e-05	9.67e-05	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—HMOX1—esophageal cancer	5e-05	9.55e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—CREBBP—esophageal cancer	4.92e-05	9.39e-05	CbGpPWpGaD
Sucralfate—EGF—Immune System—EGFR—esophageal cancer	4.88e-05	9.33e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—TYMP—esophageal cancer	4.88e-05	9.33e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—NOS3—esophageal cancer	4.87e-05	9.31e-05	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—ABCB1—esophageal cancer	4.8e-05	9.16e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CYP26A1—esophageal cancer	4.75e-05	9.07e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—ALOX15—esophageal cancer	4.63e-05	8.84e-05	CbGpPWpGaD
Sucralfate—EGF—Disease—MYC—esophageal cancer	4.61e-05	8.81e-05	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—PIK3CA—esophageal cancer	4.61e-05	8.8e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—BCL2—esophageal cancer	4.59e-05	8.77e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—ERBB2—esophageal cancer	4.56e-05	8.7e-05	CbGpPWpGaD
Sucralfate—EGF—Disease—EGFR—esophageal cancer	4.51e-05	8.62e-05	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—PIK3CA—esophageal cancer	4.48e-05	8.56e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—ERBB2—esophageal cancer	4.46e-05	8.52e-05	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—PIK3CA—esophageal cancer	4.42e-05	8.45e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—TPI1—esophageal cancer	4.42e-05	8.44e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GSTO1—esophageal cancer	4.42e-05	8.44e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—NOS3—esophageal cancer	4.4e-05	8.41e-05	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—PIK3CA—esophageal cancer	4.39e-05	8.39e-05	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—PIK3CA—esophageal cancer	4.39e-05	8.39e-05	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—TP53—esophageal cancer	4.34e-05	8.29e-05	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—TP53—esophageal cancer	4.25e-05	8.12e-05	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—TP53—esophageal cancer	4.25e-05	8.12e-05	CbGpPWpGaD
Sucralfate—EGF—Immune System—PIK3CA—esophageal cancer	4.24e-05	8.1e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—ALDOB—esophageal cancer	4.23e-05	8.09e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—HIF1A—esophageal cancer	4.22e-05	8.05e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—NOS2—esophageal cancer	4.12e-05	7.88e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—ERBB2—esophageal cancer	4.12e-05	7.87e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GAPDH—esophageal cancer	4.08e-05	7.79e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CRABP1—esophageal cancer	4.04e-05	7.72e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—KDR—esophageal cancer	4.03e-05	7.7e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—PTGS2—esophageal cancer	4.03e-05	7.69e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CCND1—esophageal cancer	4.03e-05	7.69e-05	CbGpPWpGaD
Sucralfate—EGF—Disease—PIK3CA—esophageal cancer	3.91e-05	7.48e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CDKN1A—esophageal cancer	3.89e-05	7.44e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GNG7—esophageal cancer	3.84e-05	7.34e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CDKN1A—esophageal cancer	3.81e-05	7.28e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—NOTCH1—esophageal cancer	3.8e-05	7.26e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—EP300—esophageal cancer	3.71e-05	7.08e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—CREBBP—esophageal cancer	3.7e-05	7.07e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—EP300—esophageal cancer	3.63e-05	6.93e-05	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	3.62e-05	6.91e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—ALDH2—esophageal cancer	3.6e-05	6.88e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—CDKN1A—esophageal cancer	3.52e-05	6.72e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CREBBP—esophageal cancer	3.44e-05	6.58e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GSTT1—esophageal cancer	3.42e-05	6.54e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CYP2A6—esophageal cancer	3.38e-05	6.47e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3.37e-05	6.44e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—EP300—esophageal cancer	3.35e-05	6.4e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—NOS3—esophageal cancer	3.32e-05	6.33e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—MYC—esophageal cancer	3.23e-05	6.17e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—ENO1—esophageal cancer	3.21e-05	6.13e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PTGS1—esophageal cancer	3.21e-05	6.13e-05	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.21e-05	6.12e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PSME2—esophageal cancer	3.16e-05	6.04e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PSME1—esophageal cancer	3.16e-05	6.04e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—EGFR—esophageal cancer	3.16e-05	6.03e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—EGFR—esophageal cancer	3.09e-05	5.91e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—NOS3—esophageal cancer	3.08e-05	5.89e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—MYC—esophageal cancer	2.92e-05	5.57e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—ERBB2—esophageal cancer	2.88e-05	5.51e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—EGFR—esophageal cancer	2.85e-05	5.45e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.76e-05	5.27e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—PIK3CA—esophageal cancer	2.74e-05	5.24e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CYP1B1—esophageal cancer	2.73e-05	5.21e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—PIK3CA—esophageal cancer	2.68e-05	5.13e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—TP53—esophageal cancer	2.65e-05	5.07e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CYP19A1—esophageal cancer	2.57e-05	4.9e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CCND1—esophageal cancer	2.55e-05	4.87e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—EP300—esophageal cancer	2.52e-05	4.82e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—PIK3CA—esophageal cancer	2.48e-05	4.73e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CDKN1A—esophageal cancer	2.46e-05	4.71e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—EP300—esophageal cancer	2.35e-05	4.48e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—HMOX1—esophageal cancer	2.34e-05	4.47e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.3e-05	4.39e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—ABCB1—esophageal cancer	2.25e-05	4.29e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—MYC—esophageal cancer	2.04e-05	3.9e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—EGFR—esophageal cancer	2e-05	3.82e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—PIK3CA—esophageal cancer	1.87e-05	3.56e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—TP53—esophageal cancer	1.81e-05	3.45e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—PIK3CA—esophageal cancer	1.73e-05	3.31e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.7e-05	3.24e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—TP53—esophageal cancer	1.68e-05	3.21e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CREBBP—esophageal cancer	1.5e-05	2.87e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—NOS3—esophageal cancer	1.34e-05	2.57e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PTGS2—esophageal cancer	1.23e-05	2.35e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—EP300—esophageal cancer	1.02e-05	1.95e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PIK3CA—esophageal cancer	7.56e-06	1.45e-05	CbGpPWpGaD
